Trinity Stock Executives

TRIB
 Stock
  

USD 1.09  0.05  4.39%   

Trinity Bio employes about 477 people. The company is managed by 9 executives with total tenure of roughly 115 years, averaging almost 12.0 years of service per executive having 53.0 employees per reported executive. Analysis of Trinity Bio management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Trinity Bio ADR future performance.
Additionally, take a look at World Market Map.
  
  Ronan OCaoimh  Chairman
Executive Chairman of the Board

Trinity Bio Management Team Effectiveness

Trinity Bio ADR has return on total asset (ROA) of 3.1 % which means that it generated profit of $3.1 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of (190.56) %, meaning that it created substantial loss on money invested by shareholders. Trinity Bio management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Trinity Bio Workforce Comparison

Trinity Bio ADR is currently regarded as top stock in number of employees category among related companies. The total workforce of Diagnostics & Research industry is at this time estimated at about 603. Trinity Bio totals roughly 477 in number of employees claiming about 79% of equities under Diagnostics & Research industry.

Trinity Bio Profit Margins

The company has Profit Margin (PM) of (15.1) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 6.96 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.07.

Trinity Bio ADR Benchmark Summation

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Indexes of lowest and highest values over a specified period line shows minimum and maximum index of Trinity Bio ADR price series.
.

Trinity Bio Notable Stakeholders

A Trinity Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Trinity Bio often face trade-offs trying to please all of them. Trinity Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Trinity Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ronan OCaoimh - Executive Chairman of the BoardProfile
Kevin Tansley - CFO and SecretaryProfile
Peter Coyne - Non-Executive Independent DirectorProfile
Denis Burger - Senior Non-Executive Independent DirectorProfile
James Merselis - Non-Executive Independent DirectorProfile
Clinton Severson - Non-Executive DirectorProfile
Rory Nealon - Chief Operations Officer, Director and Member of Compensation CommitteeProfile
James Walsh - Executive Director and Member of Compensation CommitteeProfile
Eric Brouwer - Chief Scientific Officer and VP CardiacProfile

About Trinity Bio Management Performance

The success or failure of an entity such as Trinity Bio ADR often depends on how effective the management is. Trinity Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Trinity management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Trinity management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market in the Americas, Africa, Asia, and Europe. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland. Trinity Bio operates under Pharmaceuticals And Biosciences classification in the United States and is traded on NASDAQ Exchange. It employs 477 people.
The data published in Trinity Bio's official financial statements usually reflect Trinity Bio's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Trinity Bio ADR. For example, before you start analyzing numbers published by Trinity accountants, it's critical to develop an understanding of what Trinity Bio's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Trinity Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Trinity Bio's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Trinity Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Trinity Bio ADR. Please utilize our Beneish M Score to check the likelihood of Trinity Bio's management to manipulate its earnings.

Trinity Bio Workforce Analysis

Traditionally, organizations such as Trinity Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Trinity Bio within its industry.

Trinity Bio Manpower Efficiency

Return on Trinity Bio Manpower

Revenue Per Employee180.6 K
Revenue Per Executive9.6 M
Net Loss Per Employee27.1 K
Net Loss Per Executive1.4 M
Working Capital Per Employee272.5 K
Working Capital Per Executive14.4 M
Additionally, take a look at World Market Map. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for analysis

When running Trinity Bio ADR price analysis, check to measure Trinity Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Bio is operating at the current time. Most of Trinity Bio's value examination focuses on studying past and present price action to predict the probability of Trinity Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Trinity Bio's price. Additionally, you may evaluate how the addition of Trinity Bio to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Is Trinity Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Bio. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Trinity Bio ADR is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Bio's value that differs from its market value or its book value, called intrinsic value, which is Trinity Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Bio's market value can be influenced by many factors that don't directly affect Trinity Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Trinity Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.